Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
25.05
+0.84 (3.47%)
At close: Oct 30, 2026, 4:00 PM EDT
25.74
+0.69 (2.75%)
After-hours: Oct 30, 2026, 7:59 PM EDT
Rapport Therapeutics Employees
Rapport Therapeutics had 84 employees as of December 31, 2025. The number of employees increased by 15 or 21.74% compared to the previous year. That makes Rapport Therapeutics the 32,545th largest employer in the world and 4,226th in the United States.
Employees
84
Change (1Y)
15
Growth (1Y)
21.74%
Revenue / Employee
$238,095
Profits / Employee
-$1,632,857
Market Cap
1.20B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 84 | 15 | 21.74% |
| Dec 31, 2024 | 69 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 828 |
| MannKind | 592 |
| Syndax Pharmaceuticals | 298 |
| Kardigan | 241 |
| Alpha Tau Medical | 121 |
| Verastem | 102 |
| Silence Therapeutics | 88 |
| Vor Biopharma | 76 |
RAPP News
- 21 hours ago - Citizens biotech analysts hold an analyst/industry conference call - TheFly
- 3 days ago - Rapport Therapeutics 8.333M share Spot Secondary priced at $21.00 - TheFly
- 3 days ago - Rapport Announces Pricing of Underwritten Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes and Concurrent Private Placement - GlobeNewsWire
- 3 days ago - Rapport announces $200M common stock, $150M convertible senior notes offerings - TheFly
- 3 days ago - Rapport Announces Proposed Public Offerings of Common Stock and Convertible Notes as well as Concurrent Private Placement - GlobeNewsWire
- 10 days ago - Rapport Therapeutics price target raised to $70 from $65 at Guggenheim - TheFly
- 10 days ago - Rapport Therapeutics price target raised to $82 from $50 at Jones - TheFly
- 10 days ago - Rapport Therapeutics price target lowered to $50 from $51 at Wells Fargo - TheFly